Introduction ExoRNA Bioscience Nanjing Co. Ltd., co-founded in September 2021 by Professor Zhang Chenyu and Dr. Meng Xia, is headquartered in Shenzhen, with subsidiaries in Nanjing and Shanghai. Focused on developing drugs for diseases without cure and unmet clinical needs, particularly in the central nervous system, ExoRNA aspires to become a global leader in platform-based innovative nucleic acid therapeutics. The company boasts a unique self-assembling exosome nucleic acid delivery platform with multiple organ targeting capabilities, the ability to cross the blood-brain barrier, high safety, and low cost, offering an all-in-one solution to current RNA drug delivery challenges. |